imaGenes GmbH Company Profile

11:21 EDT 27th July 2016 | BioPortfolio

"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most comprehensive collections of clones of mammalian and vertebrate genes in the world offered via its clone search engine GenomeCube, linked to international databases. The second major research services of imaGenes features microarray services on Affymetrix, Agilent, and NimbleGen platforms for a broad range of functional analyses. imaGenes is also offering next generation sequencing services on an Illumina Genome Analyzer System."



News Articles [148 Associated News Articles listed on BioPortfolio]

Company take-over of Slamed ING GmbH by Ratiolab GmbH

Company Ratiolab GmbH has taken over Slamed ING GmbH with effect on 05th July 2016. Ratiolab GmbH will continue the existing business activities without any change. In 1987 Slamed ING GmbH was founded...

Thermosome raises €4.6m

Thermosome GmbH, an emerging biopharmaceutical company, announced the closing of its first financing round, raising net proceeds of approximately €1.9 million from funds managed by High-Tech Gründe...

LUM GmbH starts exclusive distribution of PSI-homogenizers in several countries

With immediate effect LUM GmbH, Berlin, Germany, starts the exclusive distribution of PSI instruments in Germany, Austria, France and China. The distributorship agreement between the manufacturer Part...

LDC and Boehringer Ingelheim Join Forces

The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH and Boehringer Ingelheim International GmbH have signed an agreement providing Boehringer Ingelheim with the option to receive the excl...

Original-Research: PAION AG (von EQUITS GmbH):

Original-Research: PAION AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu PAION AG Unternehmen: PAION AG ISIN: DE000A0B65S3 Anlass der Studie: Peergroup Analyse, Initial seit: 04.05.2016 Kurszie...

Original-Research: Biofrontera AG (von EQUITS GmbH): Kaufen

Original-Research: Biofrontera AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Biofrontera AG Unternehmen: Biofrontera AG ISIN: DE0006046113 Anlass der Studie: US-Zulassung für Ameluz erteilt E...

Nachgefragt: Thomas Helle über neue Entwicklungen im Bioleaching

Auf Vermittlung der BIOPRO Baden-Württemberg GmbH trat die Biotechnologiefirma Novis GmbH in Kontakt mit dem renommierten Geomikrobiologen Prof. Dr. Andreas Kappler. Die Partner testeten erste Biolea...

Repligen acquires Atoll

Repligen Corp acquired German chromatography column manufacturer Atoll GMBH from UV-Cap GMBH for $9.1mm in cash and 538.7k shares--a total of $22.5mm. Repligen could also pay a sales milestone of $1.1...

Drugs and Medications [0 Results]


PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Brachytherapy.

To examine a novel technique for simplified placement and removal of plaque brachytherapy by fibrin glue and urokinase (medac Gmbh, Hamburg, Germany).

Preliminary Experience with a New Multidirectional Videoendoscope for Neuroendoscopic Surgical Procedures.

We assessed the applicability of a new multidirectional videoendoscope (digiCAMeleon, Karl Storz GmbH, Tuttlingen, Germany) in various neuroendoscopic procedures.

Enhanced Combined Tomography and Biomechanics Data for Distinguishing Forme Fruste Keratoconus.

To evaluate the performance of the Ocular Response Analyzer (ORA) (Reichert Ophthalmic Instruments, Depew, NY) variables and Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) tomographic parame...

The Degree of Anisocoria in Pediatric Patients With Horner Syndrome When Compared to Children Without Disease.

To study the magnitude of anisocoria in pediatric patients using the plusoptiX A08 (plusoptiX GmbH, Nuremberg, Germany) photoscreener as compared to a literature review of pediatric patients with know...

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

This is a Phase IV multi-center, randomized, open-label, cross-over, placebo study in subjects with Chronic Obstructive Pulmonary Disease (COPD) to compare inhaler-specific preference attr...

Telemedicine Monitoring of Sleep Apnea in Stroke

Study Objectives: Meta-analyses report a high prevalence of moderate to severe sleep apnea of more than 50% in stroke patients, with adherence rates for CPAP therapy of only 30%. T...

Companies [1 Associated Companies listed on BioPortfolio]

imaGenes GmbH

"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most com...

More Information about "imaGenes GmbH" on BioPortfolio

We have published hundreds of imaGenes GmbH news stories on BioPortfolio along with dozens of imaGenes GmbH Clinical Trials and PubMed Articles about imaGenes GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of imaGenes GmbH Companies in our database. You can also find out about relevant imaGenes GmbH Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record